# Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

> **NCT07237425** · PHASE1 · RECRUITING · sponsor: **Glonova Pharma Co., Ltd** · enrollment: 56 (estimated)

## Conditions studied

- Lipoma
- Submental Fullness

## Interventions

- **DRUG:** Ronkyla Plus
- **DRUG:** Placebo
- **DRUG:** Kybella

## Key facts

- **NCT ID:** NCT07237425
- **Lead sponsor:** Glonova Pharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2026-11-14
- **Final completion:** 2027-01-14
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07237425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07237425, "Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07237425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*